Jacqueline Gress

1.3k total citations
23 papers, 883 citations indexed

About

Jacqueline Gress is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Jacqueline Gress has authored 23 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 14 papers in Hepatology and 4 papers in Infectious Diseases. Recurrent topics in Jacqueline Gress's work include Hepatitis B Virus Studies (10 papers), Hepatitis C virus research (10 papers) and Liver Disease Diagnosis and Treatment (6 papers). Jacqueline Gress is often cited by papers focused on Hepatitis B Virus Studies (10 papers), Hepatitis C virus research (10 papers) and Liver Disease Diagnosis and Treatment (6 papers). Jacqueline Gress collaborates with scholars based in United States, France and Germany. Jacqueline Gress's co-authors include C. Russell Middaugh, Michael Robertson, P.K. Tsai, Janice Wahl, Stephanie O. Klopfer, Eliav Barr, Barbara J. Kuter, Carl J. Burke, David B. Volkin and Robert J. Linhardt and has published in prestigious journals such as Gastroenterology, Biochemistry and PEDIATRICS.

In The Last Decade

Jacqueline Gress

23 papers receiving 859 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacqueline Gress United States 13 526 511 258 190 72 23 883
Tanja Bauer Germany 19 800 1.5× 616 1.2× 180 0.7× 151 0.8× 10 0.1× 42 1.3k
Christina Whitten-Bauer United States 9 518 1.0× 463 0.9× 234 0.9× 376 2.0× 21 0.3× 11 1.0k
Carmen Mirabelli United States 18 232 0.4× 142 0.3× 559 2.2× 207 1.1× 17 0.2× 39 977
Richard K. Groger United States 14 443 0.8× 139 0.3× 320 1.2× 247 1.3× 39 0.5× 18 839
Yongfen Xu China 18 411 0.8× 263 0.5× 267 1.0× 320 1.7× 48 0.7× 29 1.0k
Kathie Grovit‐Ferbas United States 14 306 0.6× 75 0.1× 464 1.8× 228 1.2× 12 0.2× 15 1.2k
Alexander S. Kekulé Germany 13 767 1.5× 427 0.8× 165 0.6× 334 1.8× 35 0.5× 27 1.1k
J. D. Conradie South Africa 12 217 0.4× 208 0.4× 65 0.3× 121 0.6× 19 0.3× 28 559
Irene S. Ludwig Netherlands 17 139 0.3× 44 0.1× 126 0.5× 258 1.4× 27 0.4× 33 810
Shlomo Dagan Israel 15 530 1.0× 460 0.9× 105 0.4× 173 0.9× 9 0.1× 42 835

Countries citing papers authored by Jacqueline Gress

Since Specialization
Citations

This map shows the geographic impact of Jacqueline Gress's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacqueline Gress with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacqueline Gress more than expected).

Fields of papers citing papers by Jacqueline Gress

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacqueline Gress. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacqueline Gress. The network helps show where Jacqueline Gress may publish in the future.

Co-authorship network of co-authors of Jacqueline Gress

This figure shows the co-authorship network connecting the top 25 collaborators of Jacqueline Gress. A scholar is included among the top collaborators of Jacqueline Gress based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacqueline Gress. Jacqueline Gress is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kwo, Paul Y., Edward Gane, Cheng‐Yuan Peng, et al.. (2016). Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection. Gastroenterology. 152(1). 164–175.e4. 124 indexed citations
2.
Rockstroh, Jürgen K., Mark Nelson, Christine Katlama, et al.. (2015). Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial. The Lancet HIV. 2(8). e319–e327. 218 indexed citations
3.
Rockstroh, JK, Mark Nelson, Christine Katlama, et al.. (2015). P0887 : C-edge co-infected: phase 3 study of grazoprevir/elbasvir in patients with HCV/HIV. Journal of Hepatology. 62. S675–S675. 7 indexed citations
4.
5.
Manns, Michael P., John M. Vierling, Bruce R. Bacon, et al.. (2014). The Combination of MK-5172, Peginterferon, and Ribavirin Is Effective in Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Infection Without Cirrhosis. Gastroenterology. 147(2). 366–376.e6. 28 indexed citations
6.
Lawitz, Eric, Mark Sulkowski, Ira M. Jacobson, et al.. (2013). Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: Safety, antiviral activity, resistance, and pharmacokinetics. Antiviral Research. 99(3). 214–220. 26 indexed citations
7.
Lawitz, Eric, M. Rodríguez‐Torres, Albrecht Stoehr, et al.. (2013). A phase 2B study of MK-7009 (vaniprevir) in patients with genotype 1 HCV infection who have failed previous pegylated interferon and ribavirin treatment. Journal of Hepatology. 59(1). 11–17. 29 indexed citations
8.
9.
10.
Gress, Jacqueline, Alan Werzberger, Keith S. Reisinger, et al.. (2006). Safety, Tolerability and Immunogenicity of VAQTA Given Concomitantly versus Nonconcomitantly With Other Pediatric Vaccines in Healthy 12-Month-Old Children. The Pediatric Infectious Disease Journal. 25(10). 912–919. 9 indexed citations
11.
Kuter, Barbara J., Michelle Brown, Jonathan Hartzel, et al.. (2006). Safety and Immunogenicity of a Combination: Measles, Mumps, Rubella and Varicella Vaccine (ProQuad®). Human Vaccines. 2(5). 205–214. 38 indexed citations
12.
Reisinger, Keith S., Michelle Brown, Jin Xu, et al.. (2006). A Combination Measles, Mumps, Rubella, and Varicella Vaccine (ProQuad) Given to 4- to 6-Year-Old Healthy Children Vaccinated Previously With M-M-RII and Varivax. PEDIATRICS. 117(2). 265–272. 28 indexed citations
13.
Shinefield, Henry R., Steve Black, Laura Digilio, et al.. (2005). Evaluation of a Quadrivalent Measles, Mumps, Rubella and Varicella Vaccine in Healthy Children. The Pediatric Infectious Disease Journal. 24(8). 665–669. 76 indexed citations
14.
Su, L. Joseph, Sharon E. Frey, Jacqueline Gress, et al.. (2000). Measuring injection-site pain associated with vaccine administration in adults: a randomised, double-blind, placebo-controlled clinical trial.. PubMed. 5(6). 359–65. 13 indexed citations
15.
Nalin, David R., et al.. (1995). Monthly Update: Anti-infectives: VAQTA: Merck's hepatitis A vaccine, purified, inactivated. Expert Opinion on Investigational Drugs. 4(12). 1313–1319. 4 indexed citations
16.
Sanyal, Gautam, et al.. (1995). Spectroscopic characterization of tick anticoagulant peptide. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1249(1). 100–108. 6 indexed citations
17.
18.
Tsai, P.K., Karen Thompson, Mark W. Bruner, et al.. (1993). Formulation Design of Acidic Fibroblast Growth Factor. Pharmaceutical Research. 10(5). 649–659. 87 indexed citations
19.
Volkin, David B., P.K. Tsai, Jacqueline Gress, et al.. (1993). Physical Stabilization of Acidic Fibroblast Growth Factor by Polyanions. Archives of Biochemistry and Biophysics. 300(1). 30–41. 109 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tanja Bauer Breakdown of academic impact, for papers by Christina Whitten-Bauer Breakdown of academic impact, for papers by Carmen Mirabelli Breakdown of academic impact, for papers by Richard K. Groger Breakdown of academic impact, for papers by Yongfen Xu Breakdown of academic impact, for papers by Kathie Grovit‐Ferbas Breakdown of academic impact, for papers by Alexander S. Kekulé Breakdown of academic impact, for papers by J. D. Conradie Breakdown of academic impact, for papers by Irene S. Ludwig Breakdown of academic impact, for papers by Shlomo Dagan
Rankless by CCL
2026